EGFR-Targeted Therapy: A New Beginning

AACR 2018: First-Line Management of Advanced NSCLC Enters New Era

PD-L1 IHC Blueprint Project: Ongoing Progress Toward Consistency Among Assays

2017 Lung Cancer SPORE Workshop

ESMO-IASLC European Lung Cancer Congress

Lung Cancer 360 Forum Overview: C.A.I.R.O Journal Club’s Fourth Anniversary

PACIFIC Trial Leads to Durvalumab Approval in United States

Takeaways from KEYNOTE-021 and IMpower 150 on Combination Chemotherapy and Checkpoint Inhibition in NSCLC

Targeted Therapies Meeting Focuses on Upcoming Research Advances in Lung Cancer

ALK Testing in Europe

Immunotherapy Adverse-Event Treatment Resource Guide

Lung Cancer Immunotherapy Meeting to Discuss New Topics, Emerging Themes